BMS-936564/MDX-1338: A Fully Human Anti-CXCR4 Antibody Induces Apoptosis In Vitro and Shows Antitumor Activity In Vivo in Hematologic MalignanciesKUHNE, Michelle R; MULVEY, Tanya; COHEN, Lewis J et al.Clinical cancer research (Print). 2013, Vol 19, Num 2, pp 357-366, issn 1078-0432, 10 p.Article

Plerixafor 'just in time' for stem cell mobilization in a normal donorSCHRIBER, J; FAUBLE, V; SPROAT, L. O et al.Bone marrow transplantation (Basingstoke). 2011, Vol 46, Num 7, pp 1026-1027, issn 0268-3369, 2 p.Article

Prospective study of mobilization kinetics up to 18 hours after late-afternoon dosing of plerixaforSHI, Patricia A; MILLER, Lorraine K; ISOLA, Luis M et al.Transfusion (Philadelphia, PA). 2014, Vol 54, Num 5, pp 1263-1268, issn 0041-1132, 6 p.Article

The evolving role of plerixafor in hematopoietic progenitor cell mobilizationTANHEHCO, Yvette C; VOGL, Dan T; STADTMAUER, Edward A et al.Transfusion (Philadelphia, PA). 2013, Vol 53, Num 10, pp 2314-2326, issn 0041-1132, 13 p., 1Article

A specific time course for mobilization of peripheral blood CD34+ cells after plerixafor injection in very poor mobilizer patients: impact on the timing of the apheresis procedureLEFRERE, François; MAUGE, Laeticia; REA, Delphine et al.Transfusion (Philadelphia, PA). 2013, Vol 53, Num 3, pp 564-569, issn 0041-1132, 6 p.Article

Effectiveness and cost analysis of just-in-time salvage plerixafor administration in autologous transplant patients with poor stem cell mobilization kineticsJIE LI; HAMILTON, Ellie; LONIAL, Sagar et al.Transfusion (Philadelphia, PA). 2011, Vol 51, Num 10, pp 2175-2182, issn 0041-1132, 8 p.Article

AMD3100 for urgent PBSC mobilization and allogeneic transplantation from a normal donor after failed marrow harvestLEOTTA, S; POIDOMANI, M; MAURO, E et al.Bone marrow transplantation (Basingstoke). 2011, Vol 46, Num 2, pp 314-316, issn 0268-3369, 3 p.Article

Plerixafor with and without chemotherapy in poor mobilizers: results from the German compassionate use programHÜBEL, K; FRESEN, M. M; HEITS, F et al.Bone marrow transplantation (Basingstoke). 2011, Vol 46, Num 8, pp 1045-1052, issn 0268-3369, 8 p.Article

Plerixafor given before the third leukapheresis to rescue an unsuccessful stem cell mobilization with CY and G-CSFNIMMAGADDA, S; SWEISS, K; MAHMUD, N et al.Bone marrow transplantation (Basingstoke). 2010, Vol 45, Num 6, pp 1121-1122, issn 0268-3369, 2 p.Article

Rescue from failed growth factor and/or chemotherapy HSC mobilization with G-CSF and plerixafor (AMD3100): an institutional experienceFOWLER, C. J; DUNN, A; MAZIARZ, R. T et al.Bone marrow transplantation (Basingstoke). 2009, Vol 43, Num 12, pp 909-917, issn 0268-3369, 9 p.Article

Addition of plerixafor for CD34+ cell mobilization in six healthy stem cell donors ensured satisfactory grafts for transplantationHAUGE, Anne Werner; HAASTRUP, Eva Kannik; SENGELØV, Henrik et al.Transfusion (Philadelphia, PA). 2014, Vol 54, Num 4, pp 1055-1058, issn 0041-1132, 4 p.Article

Genetics on a WHIMOMAR AL USTWANI, Omar; KURZROCK, Razelle; WETZLER, Meir et al.British journal of haematology. 2014, Vol 164, Num 1, pp 15-23, issn 0007-1048, 9 p.Article

Second time a charm? Remobilization of peripheral blood stem cells with plerixafor in patients who previously mobilized poorly despite using plerixafor as a salvage agentSHAN YUAN; NADEMANEE, Auayporn; KRISHNAN, Amrita et al.Transfusion (Philadelphia, PA). 2013, Vol 53, Num 12, pp 3244-3250, issn 0041-1132, 7 p.Article

Clinical experience with a simple algorithm for plerixafor utilization in autologous stem cell mobilizationCHEN, Al; BAINS, T; MURRAY, S et al.Bone marrow transplantation (Basingstoke). 2012, Vol 47, Num 12, pp 1526-1529, issn 0268-3369, 4 p.Article

Safe and effective use of plerixafor plus G-CSF in dialysis-dependent renal failurePINTO, Valeria; CASTELLI, Andrea; GAIDANO, Gianluca et al.American journal of hematology. 2010, Vol 85, Num 6, pp 461-462, issn 0361-8609, 2 p.Article

Experience with Plerixafor for Hematopoietic Cell Mobilization in Nine Patients with Germ Cell TumorsO'HARA, V. J. Daphne; KARR, Alissa H; SRIVASTAVA, Shivani et al.Pharmacotherapy. 2014, Vol 34, Num 1, pp 85-88, issn 0277-0008, 4 p.Article

Similar dynamics of intraapheresis autologous CD34+ recruitment and collection efficiency in patients undergoing mobilization with or without plerixaforSCHADE, Henning; CHHABRA, Saurabh; COSTA, Luciano J et al.Transfusion (Philadelphia, PA). 2014, Vol 54, Num 12, pp 3131-3137, issn 0041-1132, 7 p.Article

Higher BMI is not a barrier to stem cell mobilization with standard doses of plerixafor and G-CSFBASAK, G. W; WIKTOR-JEDRZEJCZAK, W; LEMOLI, R et al.Bone marrow transplantation (Basingstoke). 2012, Vol 47, Num 7, pp 1003-1005, issn 0268-3369, 3 p.Article

Preemptive dosing of plerixafor given to poor stem cell mobilizers on day 5 of G-CSF administrationHORWITZ, M. E; CHUTE, J. P; GASPARETTO, C et al.Bone marrow transplantation (Basingstoke). 2012, Vol 47, Num 8, pp 1051-1055, issn 0268-3369, 5 p.Article

Successful mobilization of PBSCs in a healthy volunteer donor by addition of plerixafor after failure of mobilization with G-CSF aloneNEUMANN, T; KRÜGER, W. H; BUSEMANN, C et al.Bone marrow transplantation (Basingstoke). 2011, Vol 46, Num 5, pp 762-763, issn 0268-3369, 2 p.Article

G-CSF plus plerixafor (Mozobil) to mobilize hematopoietic stem cells in patients with thrombocytopenia or leukopenia prior to auto-SCTMICALLEF, I. N; JACOBSEN, E. D; SHAUGHNESSY, P et al.Bone marrow transplantation (Basingstoke). 2013, Vol 48, Num 2, pp 303-304, issn 0268-3369, 2 p.Article

Mobilization studies in complement-deficient mice reveal that optimal AMD3100 mobilization of hematopoietic stem cells depends on complement cascade activation by AMD3100-stimulated granulocytesLEE, H. M; WYSOCZYNSKI, M; LIU, R et al.Leukemia. 2010, Vol 24, Num 3, pp 573-582, issn 0887-6924, 10 p.Article

Mobilization of PBSCs in poor mobilizers with POEMS syndrome using G-CSF with plerixaforSHIMIZU, N; SAKAIDA, E; ISEKI, T et al.Bone marrow transplantation (Basingstoke). 2012, Vol 47, Num 12, pp 1587-1588, issn 0268-3369, 2 p.Article

Plerixafor : In Patients with Non-Hodgkin's Lymphoma or Multiple MyelomaWAGSTAFF, Antona J.Drugs (Basel). 2009, Vol 69, Num 3, pp 319-326, issn 0012-6667, 8 p.Article

Plerixafor and G-CSF versus placebo and G-CSF to mobilize hematopoietic stem cells for autologous stem cell transplantation in patients with multiple myelomaDIPERSIO, John F; STADTMAUER, Edward A; COOPER, Dennis et al.Blood. 2009, Vol 113, Num 23, pp 5720-5726, issn 0006-4971, 7 p.Article